A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Recent news on Humate-P


Humate-P(R) Approved To Prevent Excessive Bleeding In Patients ...  -  May 1, 2007
Medical News Today (press release),..."Humate-P, which for years has been used successfully to treat spontaneous bleeding episodes in VWD patients, can now be administered to help prevent

Humate-P(R) Approved to Prevent Excessive Bleeding in Patients ...  -  Apr 30, 2007
PR-Inside.com (Pressemitteilung),...in the United States - that demonstrate the hemostatic efficacy and safety of Humate-P for VWD patients undergoing major, minor and oral surgical procedures

Humate-P Approved To Prevent Excessive Bleeding In Patients With ...  -  Apr 30, 2007
eMaxHealth.com,Humate-P, CSL Behring's factor replacement therapy for the treatment of hemophilia A and von Willebrand disease, has been approved by the US Food and Drug

FDA Approves Drug For Common Bleeding Disorder, Humate-P  -  Apr 28, 2007
Medical News Today,Humate-P (Antihemophilic Factor/von Willebrand Factor Complex), a drug designed for the treatment of excessive bleeding during and after surgery,

Humate-P Approved for Prevention of Excessive Bleeding in von ...  -  Apr 30, 2007
Facts and Comparisons,The FDA has approved CSL Behring's Humate-P (antihemophilic factor/von Willebrand factor complex [human]) to prevent excessive bleeding during and after

FDA approves new treatment for von Willebrand disease  -  May 1, 2007
News-Medical.net,The US Food and Drug Administration (FDA) has approved Humate-P (Antihemophilic Factor/von Willebrand Factor Complex) for the prevention of excessive

FDA Approves Product to Treat Common Bleeding Disorder  -  Apr 30, 2007
DG NewsHumate-P is the second biological product to be approved for the management of surgery and invasive procedures in patients with vWD in whom the medication

FDA Approves Product To Treat Common Bleeding Disorder  -  Apr 28, 2007
eMaxHealth.com,The US Food and Drug Administration approved Humate-P for the prevention of excessive bleeding during and after surgery in certain patients with mild to

Health and Science News Roundup  -  Apr 30, 2007
Monsters and Critics.com,WASHINGTON, April 30 (UPI) -- The US Food and Drug Administration has approved Humate-P for the treatment of a specific bleeding disorder called von

FDA OKs drug to treat bleeding disorder  -  Apr 30, 2007
PhysOrg.com,The US Food and Drug Administration has approved Humate-P for the treatment of a specific bleeding disorder called von Willebrand disease.

New Treatment for Bleeding Disorder Approved  -  Apr 30, 2007
Austin American-Statesman (subscription),Humate-P is the second biological product to be approved for surgery and invasive procedures in patients with vWD who don't respond to the medication

US government grants wider indication for anti-bleeding product  -  Apr 27, 2007
International Herald Tribune,WASHINGTON: The Food and Drug Administration said Friday it approved Humate-P for the prevention of excessive bleeding during and after surgery in certain

FDA Expands Use for Anti-Bleeding Drug  -  Apr 27, 2007
Houston Chronicle,WASHINGTON — The Food and Drug Administration said Friday it approved Humate-P for the prevention of excessive bleeding during and after surgery in certain

US government grants wider indication for anti-bleeding product  -  Apr 28, 2007
China Post,The Food and Drug Administration said Friday it approved Humate-P for the prevention of excessive bleeding during and after surgery in certain patients with

Pharma Sector: Few Newsmakers Of The Week - Idenix, Nabi, CSL ...  -  May 5, 2007
Trading Markets,Monday, the FDA approved Australia-based CSL Behring's Humate-P, a drug to prevent excessive bleeding during and after surgery in patients with von

ZLB Behring Announces Availability of Humate-P(R) with Smaller Diluent  -  Apr 12, 2007
Drug Newswire (press release),The new formulation, which bears the current safety and efficacy profile of Humate-P, offers added convenience to patients, healthcare professionals,

FDA eyes factor VIII products  -  Dec 14, 2006
Monsters and Critics.com,This includes Baxter`s Hemofil and Monare, ZLB Behring`s Monoclate-P and Humate-P, Grifols` Alphanate and Talecris` Koate.


This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional